Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users.

Amendola, A; Tanzi, E; Zappa, A; Colzani, D; Boschini, A; Musher, D M; Zanetti, A R

Amendola, A; Tanzi, E; Zappa, A; Colzani, D; Boschini, A; Musher, D M; Zanetti, A R.

Affiliation

Amendola A; Institute of Virology, University of Milan, Via Pascal 38, 20133, Milan, Italy.

Vaccine ; 20(31-32): 3720-4, 2002 Nov 01.

Article in En | MEDLINE | ID: mdl-12399200

Subject(s)

HIV Infections/therapy; HIV-1/immunology; HIV-1/isolation & purification; Pneumococcal Vaccines/adverse effects; Pneumococcal Vaccines/immunology; Polysaccharides, Bacterial/adverse effects; Polysaccharides, Bacterial/immunology; Substance Abuse, Intravenous/therapy; Adult; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes/immunology; CD4-Positive T-Lymphocytes/metabolism; DNA, Viral/blood; Female; HIV Antibodies/biosynthesis; HIV Antibodies/blood; HIV Infections/drug therapy; HIV Seronegativity/immunology; HIV Seropositivity/immunology; HIV-1/genetics; Humans; Male; Middle Aged; Phenotype; Pneumococcal Vaccines/therapeutic use; Polysaccharides, Bacterial/therapeutic use; Proviruses/genetics; RNA, Viral/blood; Substance Abuse, Intravenous/drug therapy; T-Lymphocyte Subsets/immunology; T-Lymphocyte Subsets/metabolism; Viral Load

Search on Google

XML

PubMed Links

Collection: 01-internacional Health context: 2_ODS3 / 4_TD Database: MEDLINE Main subject: Polysaccharides, Bacterial / HIV Infections / Substance Abuse, Intravenous / HIV-1 / Pneumococcal Vaccines Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Vaccine Year: 2002 Document type: Article

Search on Google

XML

PubMed Links